How to cite this WIREs title:
WIREs Nanomed Nanobiotechnol

Impact Factor: 7.689

Nano‐sensing and nano‐therapy targeting central players in iron homeostasis

Advanced Review

Ning Gu, Yan Li, Linyuan Wu

Published Online: Sep 07 2020

DOI: 10.1002/wnan.1667

Full article on Wiley Online Library: HTML PDF

Can't access this content? Tell your librarian.

Abstract Iron plays vital roles in many life activities and it is strictly controlled via elaborate metabolic system. Growing evidence has suggested that the dysfunctional iron homeostasis is implicated to many refractory diseases including cancers and neurodegenerations. Systemic and cellular iron are regulated through different pathways but are meanwhile interconnecting with each other via a few key regulators, whose abnormal expressions are often found to be the root causes of many iron disorders. Nano‐sensing techniques have enabled the detection and monitoring of such central players, which provide rich information for the iron homeostasis profile through multiplexing and flexible designs. In addition to general sensing, nanoprobes are capable of target imaging and precise local access, which are particularly beneficial for revealing the conditions of intra‐/extracellular environments. Nanomaterials have also been applied in some therapies, targeting the aberrant iron metabolism. Various iron uptake pathways have been utilized for target drug delivery and iron level manipulation, while abnormal iron content is notably useful in tumor killing. With brief introduction to the significance of iron homeostasis, this review includes recent works regarding the nanotechnology that has been applied in iron‐related diagnostic and therapeutic applications. This article is categorized under: Diagnostic Tools > Biosensing Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Diagnostic Tools > in vivo Nanodiagnostics and Imaging

Major iron flow in systemic iron regulation. Iron in plasma is mostly bound to transferrin (Tf) and travels along with the circulation. Major part of iron in Tf is extracted and consumed in bone marrow to produced new erythrocytes, while the aged ones are recycled by macrophages, sending iron back to the pool. Iron can also be stored in hepatocytes and get released according to different circumstances. Iron losses are compensated by duodenal iron adsorption from foods and medicines, which maintain the overall systemic iron balance. Iron export from cell to plasma relies on ferroportin (Fpn), which is negatively controlled by hepcidin, a peptide secreted from hepatocytes

[ Normal View | Magnified View ]

Strategic directions for iron‐based cancer therapies with their existing and possible forms. The induced ferroptosis and apoptosis can work in synergy with greater tumor killing efficacy, while the treatment specificity is also improved through the iron uptake pathways. More combinations could be considered (marked in gray which has not been reported so far) in perspective of iron regulation, such as how to specifically target the microenvironment between tumor cells and TAMs, and how to enhance the cancer therapy by introducing ferroptosis from the inside, meanwhile arousing immune responses from the outside

[ Normal View | Magnified View ]

Iron related nano‐therapies for cancers: target drug delivery using nanomaterials and iron uptake pathways; cell ferroptosis induction through additional iron dosing and intracellular interventions of the ferroptosis regulation systems; oriented macrophage polarization by iron oxide nanoparticles

[ Normal View | Magnified View ]

Iron chelation and iron supplement therapies with nanomaterials. (a) Iron chelation therapy has been applied in some neurodegenerative diseases. Nanomaterials with modifications can promote drug penetration through the blood brain barrier (BBB), which brings better efficiency for iron chelators to reduce iron and reactive oxygen species (ROS) damage in the lesion parts. (b) Iron supplement utilizing iron‐base nanoparticles mainly takes effect through the macrophages endocytosis and further bioavailable iron (Tf‐Fe2) release, which is more efficient compares to many traditional iron supplement therapies

[ Normal View | Magnified View ]

Local detection of key regulators in iron homeostasis targeting their specific traits. (a) The alternations on the magnetic spin relaxation of NV in diamond were visualized into fluorescence signals for ferritin detection (Reprinted with permission from Ziem et al. (2013). Copyright 2013 American Chemical Society); (b) Iron binding properties of ferritin were utilized for ferric iron and apoferritin detection (Reprinted with permission from Han et al. (2016). Copyright 2016 Elsevier); (c) Ferrous iron was measured by electrodes in nanopipette modified with iron binding proteins (Reprinted with permission from Bulbul et al. (2018). Copyright 2018 American Chemical Society); (d) Fluorescence can be restored through ferric ion‐catalyzed destruction of the quenching encapsulation of fluorescent NPs (Reprinted with permission from W. Zhang et al. (2019). Copyright 2019 Elsevier); Tumor cell imaging through (e) TfR‐mediated endocytosis (Reprinted with permission from Y. Wang et al. (2013). Copyright 2013 Elsevier) and (f) TfR surface binding with catalytic SIONPs and coloration effect (Reprinted with permission from Weerathunge et al. (2019). Copyright 2019 American Chemical Society)

[ Normal View | Magnified View ]

General nano‐sensing platforms for detecting key players in iron homeostasis. The specific target capturing is mainly based on antigen–antibody interaction (a–e) and engineered MIP binding (f–h). Modified with corresponding antibodies, protein detections were implemented on (a) ELISA with AuNPs, (b) photonic crystals with IONPs, (c) dual‐mode fluorometric/colorimetric sensing with AuNPs and carbon dots, (d) LSPR detection in microfluid device with AuNPs, and (e) semiconductor sensing on a nanostructured FET device with a poly‐Si nanowire. Protein recognition through MIP was applied in (f) SPR sensing, (g) fluorescent detection with magnetic NPs, and (h) electrochemical measurement

[ Normal View | Magnified View ]

Hepcidin‐mediated iron regulation as host defense and interplays with macrophage and inflammatory effect under different systemic iron status. (a) When systemic iron is at balance, the pathogens will stimulate inflammation and hepcidin expression to sequester iron from pathogens. When there is iron overload, the effect is further promoted which blunts the response to pathogens. (b) When iron is deficient, the hepcidin expression is inhibited. Since the need of erythropoiesis outplays the host defense mechanism, chronic inflammation is often accompanied with iron deficiency anemia

[ Normal View | Magnified View ]

Cellular iron metabolic pathways and iron homeostasis. Apart from the cancer‐specific pathway through lipocalin 2 (Lcn‐2) for acquiring iron, iron is usually uptake by the cell in free form, or bound with transferrin (Tf), heme alone or heme in hemoglobin. Depending on their corresponding receptors and internalization process, iron is released into the LIB mostly as ferrous state for later distribution. Available iron is partially stored in the iron‐sequestering protein ferritin for later use, while the rest is transported into mitochondria and involved in producing substantial elements such as heme and iron‐sulfur clusters. Iron‐loaded heme can exit mitochondria via 1b isoform of FLVCR (feline leukemia virus subgroup C cellular receptor) and later get secreted from cell through another isoform FLVCR1a. Excessive iron in LIB is sent out of the cell through ferroportin (Fpn) mediated efflux, with the exported iron soon be oxidized into ferric state and put back to the circulation by binding to transferrin

[ Normal View | Magnified View ]

References

Agoro,, R., Taleb,, M., Quesniaux,, V. F. J., & Mura,, C. (2018). Cell iron status influences macrophage polarization. PLoS One, 13(5), e0196921. https://doi.org/10.1371/journal.pone.0196921
Alkhateeb,, A. A., Han,, B., & Connor,, J. R. (2013). Ferritin stimulates breast cancer cells through an iron‐independent mechanism and is localized within tumor‐associated macrophages. Breast Cancer Research and Treatment, 137(3), 733–744. https://doi.org/10.1007/s10549-012-2405-x
Ambroszkiewicz,, J., Klemarczyk,, W., Mazur,, J., Gajewska,, J., Rowicka,, G., Strucinska,, M., & Chelchowska,, M. (2017). Serum hepcidin and soluble transferrin receptor in the assessment of iron metabolism in children on a vegetarian diet. Biological Trace Element Research, 180(2), 182–190. https://doi.org/10.1007/s12011-017-1003-5
Andrews,, S. C., Robinson,, A. K., & Rodriguez‐Quinones,, F. (2003). Bacterial iron homeostasis. FEMS Microbiology Reviews, 27(2–3), 215–237. https://doi.org/10.1016/S0168-6445(03)00055-X
Angeli,, J. P. F., Shah,, R., Pratt,, D. A., & Conrad,, M. (2017). Ferroptosis inhibition: Mechanisms and opportunities. Trends in Pharmacological Sciences, 38(5), 489–498. https://doi.org/10.1016/j.tips.2017.02.005
Bao,, W., Liu,, X., Lv,, Y., Lu,, G.‐H., Li,, F., Zhang,, F., … Li,, Y. (2019). Nanolongan with multiple on‐demand conversions for ferroptosis–apoptosis combined anticancer therapy. ACS Nano, 13(1), 260–273. https://doi.org/10.1021/acsnano.8b05602
Bulbul,, G., Liu,, G., Vithalapur,, N. R., Atilgan,, C., Sayers,, Z., & Pourmand,, N. (2018). Employment of iron‐binding protein from Haemophilus influenzae in functional nanopipettes for iron monitoring. ACS Chemical Neuroscience, 10(4), 1970–1977. https://doi.org/10.1021/acschemneuro.8b00263
Cai,, D., Ren,, L., Zhao,, H., Xu,, C., Zhang,, L., Yu,, Y., … Chiles,, T. C. (2010). A molecular‐imprint nanosensor for ultrasensitive detection of proteins. Nature Nanotechnology, 5(8), 597–601. https://doi.org/10.1038/nnano.2010.114
Camacho,, A., Simão,, M., Ea,, H.‐K., Cohen‐Solal,, M., Richette,, P., Branco,, J., & Cancela,, M. (2016). Iron overload in a murine model of hereditary hemochromatosis is associated with accelerated progression of osteoarthritis under mechanical stress. Osteoarthritis and Cartilage, 24(3), 494–502. https://doi.org/10.1016/j.joca.2015.09.007
Camaschella,, C., & Nai,, A. (2016). Ineffective erythropoiesis and regulation of iron status in iron loading anaemias. British Journal of Haematology, 172(4), 512–523. https://doi.org/10.1111/bjh.13820
Cenci,, L., Andreetto,, E., Vestri,, A., Bovi,, M., Barozzi,, M., Iacob,, E., … Bossi,, A. M. (2015). Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin‐25. Journal of Nanobiotechnology, 13, 51. https://doi.org/10.1186/s12951-015-0115-3
Cenci,, L., Piotto,, C., Bettotti,, P., & Maria Bossi,, A. (2018). Study on molecularly imprinted nanoparticle modified microplates for pseudo‐ELISA assays. Talanta, 178, 772–779. https://doi.org/10.1016/j.talanta.2017.10.018
Chen,, H. J., Attieh,, Z. K., Syed,, B. A., Kuo,, Y. M., Stevens,, V., Fuqua,, B. K., … McArdle,, H. J. (2010). Identification of zyklopen, a new member of the vertebrate multicopper ferroxidase family, and characterization in rodents and human cells. Journal of Nutrition, 140(10), 1728–1735. https://doi.org/10.3945/jn.109.117531
Chung,, I.‐H., Wu,, T.‐I., Liao,, C.‐J., Hu,, J.‐Y., Lin,, Y.‐H., Tai,, P.‐J., … Lin,, K.‐H. (2016). Overexpression of lipocalin 2 in human cervical cancer enhances tumor invasion. Oncotarget, 7(10), 11113. https://doi.org/10.18632/oncotarget.7096
Cook,, J. D., Finch,, C. A., & Smith,, N. J. (1976). Evaluation of the iron status of a population. Blood, 48(3), 449–455. https://doi.org/10.1182/blood.V48.3.449.bloodjournal483449
Cook,, J. D., Flowers,, C. H., & Skikne,, B. S. (2003). The quantitative assessment of body iron. Blood, 101(9), 3359–3364. https://doi.org/10.1182/blood-2002-10-3071
Core,, A. B., Canali,, S., & Babitt,, J. L. (2014). Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis. Frontiers in Pharmacology, 5, 104. https://doi.org/10.3389/fphar.2014.00104
Costa da Silva,, M., Breckwoldt,, M. O., Vinchi,, F., Correia,, M. P., Stojanovic,, A., Thielmann,, C. M., … Platten,, M. (2017). Iron induces anti‐tumor activity in tumor‐associated macrophages. Frontiers in Immunology, 8, 1479. https://doi.org/10.3389/fimmu.2017.01479
Crielaard,, B. J., Lammers,, T., & Rivella,, S. (2017). Targeting iron metabolism in drug discovery and delivery. Nature Reviews Drug Discovery, 16(6), 400–423. https://doi.org/10.1038/nrd.2016.248
Dewey,, K. G., & Oaks,, B. M. (2017). U‐shaped curve for risk associated with maternal hemoglobin, iron status, or iron supplementation. American Journal of Clinical Nutrition, 106(6), 1694s–1702s. https://doi.org/10.3945/ajcn.117.156075
Dixon,, S. J., Lemberg,, K. M., Lamprecht,, M. R., Skouta,, R., Zaitsev,, E. M., Gleason,, C. E., … Stockwell,, B. R. (2012). Ferroptosis: An iron‐dependent form of nonapoptotic cell death. Cell, 149(5), 1060–1072. https://doi.org/10.1016/j.cell.2012.03.042
Dong,, D., Zhang,, G., Yang,, J., Zhao,, B., Wang,, S., Wang,, L., … Shang,, P. (2019). The role of iron metabolism in cancer therapy focusing on tumor‐associated macrophages. Journal of Cellular Physiology, 234(6), 8028–8039. https://doi.org/10.1002/jcp.27569
Donovan,, A., Brownlie,, A., Zhou,, Y., Shepard,, J., Pratt,, S. J., Moynihan,, J., … Zon,, L. I. (2000). Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature, 403(6771), 776–781. https://doi.org/10.1038/35001596
Donovan,, A., Lima,, C. A., Pinkus,, J. L., Pinkus,, G. S., Zon,, L. I., Robine,, S., & Andrews,, N. C. (2005). The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metabolism, 1(3), 191–200. https://doi.org/10.1016/j.cmet.2005.01.003
Drakesmith,, H., Nemeth,, E., & Ganz,, T. (2015). Ironing out ferroportin. Cell Metabolism, 22(5), 777–787. https://doi.org/10.1016/j.cmet.2015.09.006
Dunaief,, J. L., Richa,, C., Franks,, E. P., Schultze,, R. L., Aleman,, T. S., Schenck,, J. F., … Brooks,, D. G. (2005). Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload. Ophthalmology, 112(6), 1062–1065. https://doi.org/10.1016/j.ophtha.2004.12.029
Ermakova,, A., Pramanik,, G., Cai,, J.‐M., Algara‐Siller,, G., Kaiser,, U., Weil,, T., … Plenio,, M. B. (2013). Detection of a few metallo‐protein molecules using color centers in nanodiamonds. Nano Letters, 13(7), 3305–3309. https://doi.org/10.1021/nl4015233
Fernández‐Real,, J. M., McClain,, D., & Manco,, M. (2015). Mechanisms linking glucose homeostasis and iron metabolism toward the onset and progression of type 2 diabetes. Diabetes Care, 38(11), 2169–2176. https://doi.org/10.2337/dc14-3082
Fracasso,, G., Falvo,, E., Colotti,, G., Fazi,, F., Ingegnere,, T., Amalfitano,, A., … Morea,, V. (2016). Selective delivery of doxorubicin by novel stimuli‐sensitive nano‐ferritins overcomes tumor refractoriness. Journal of Controlled Release, 239, 10–18. https://doi.org/10.1016/j.jconrel.2016.08.010
Fuqua,, B. K., Lu,, Y., Darshan,, D., Frazer,, D. M., Wilkins,, S. J., Wolkow,, N., … Vulpe,, C. D. (2014). The multicopper ferroxidase hephaestin enhances intestinal iron absorption in mice. PLoS One, 9(6), e98792. https://doi.org/10.1371/journal.pone.0098792
Ganz,, T. (2013). Systemic iron homeostasis. Physiological Reviews, 93(4), 1721–1741. https://doi.org/10.1152/physrev.00008.2013
Ganz,, T., & Nemeth,, E. (2012). Hepcidin and iron homeostasis. Biochimica et Biophysica Acta‐Molecular Cell Research, 1823(9), 1434–1443. https://doi.org/10.1016/j.bbamcr.2012.01.014
Girelli,, D., Nemeth,, E., & Swinkels,, D. W. (2016). Hepcidin in the diagnosis of iron disorders. Blood, 127(23), 2809–2813. https://doi.org/10.1182/blood-2015-12-639112
Go,, Y.‐M., & Jones,, D. P. (2010). Redox control systems in the nucleus: Mechanisms and functions. Antioxidants %26 Redox Signaling, 13(4), 489–509. https://doi.org/10.1089/ars.2009.3021
Goswami,, T., & Andrews,, N. C. (2006). Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. Journal of Biological Chemistry, 281(39), 28494–28498. https://doi.org/10.1074/jbc.C600197200
Goswami,, U., Dutta,, A., Raza,, A., Kandimalla,, R., Kalita,, S., Ghosh,, S. S., & Chattopadhyay,, A. (2018). Transferrin–copper nanocluster–doxorubicin nanoparticles as targeted theranostic cancer nanodrug. ACS Applied Materials %26 Interfaces, 10(4), 3282–3294. https://doi.org/10.1021/acsami.7b15165
Green,, R., Charlton,, R., Seftel,, H., Bothwell,, T., Mayet,, F., Adams,, B., … Layrisse,, M. (1968). Body iron excretion in man: A collaborative study. American Journal of Medicine, 45(3), 336–353. https://doi.org/10.1016/0002-9343(68)90069-7
Gregory,, A., & Hayflick,, S. J. (2005). Neurodegeneration with brain iron accumulation. Folia Neuropathologica, 43(4), 286–296.
Gunshin,, H., Mackenzie,, B., Berger,, U. V., Gunshin,, Y., Romero,, M. F., Boron,, W. F., … Hediger,, M. A. (1997). Cloning and characterization of a mammalian proton‐coupled metal‐ion transporter. Nature, 388(6641), 482–488. https://doi.org/10.1038/41343
Han,, C., Wang,, R., Wang,, K., Xu,, H., Sui,, M., Li,, J., & Xu,, K. (2016). Highly fluorescent carbon dots as selective and sensitive “on‐off‐on” probes for iron (III) ion and apoferritin detection and imaging in living cells. Biosensors and Bioelectronics, 83, 229–236. https://doi.org/10.1016/j.bios.2016.04.066
Hentze,, M. W., Muckenthaler,, M. U., Galy,, B., & Camaschella,, C. (2010). Two to tango: Regulation of mammalian iron metabolism. Cell, 142(1), 24–38. https://doi.org/10.1016/j.cell.2010.06.028
Hercberg,, S., Chauliac,, M., Devanlay,, M., Galan,, P., Pureur,, J. L., Soustre,, Y., … Dupin,, H. (1986). Evaluation of the iron status of a rural‐population in South Benin. Nutrition Research, 6(6), 627–634. https://doi.org/10.1016/S0271-5317(86)80004-5
Hershko,, C. (2018). Assessment of iron deficiency. Haematologica, 103(12), 1939–1942. https://doi.org/10.3324/haematol.2018.205575
Hoshi,, K., Matsumoto,, Y., Ito,, H., Saito,, K., Honda,, T., Yamaguchi,, Y., & Hashimoto,, Y. (2017). A unique glycan‐isoform of transferrin in cerebrospinal fluid: A potential diagnostic marker for neurological diseases. Biochimica et Biophysica Acta‐General Subjects, 1861(10), 2473–2478. https://doi.org/10.1016/j.bbagen.2017.07.005
Hu,, S. W., Qiao,, S., Xu,, B. Y., Peng,, X., Xu,, J. J., & Chen,, H. Y. (2017). Dual‐functional carbon dots pattern on paper chips for Fe(3+) and ferritin analysis in whole blood. Analytical Chemistry, 89(3), 2131–2137. https://doi.org/10.1021/acs.analchem.6b04891
Jiang,, L., Kon,, N., Li,, T. Y., Wang,, S. J., Su,, T., Hibshoosh,, H., … Gu,, W. (2015). Ferroptosis as a p53‐mediated activity during tumour suppression. Nature, 520(7545), 57–62. https://doi.org/10.1038/nature14344
Kim,, B. J., Ahn,, S. H., Bae,, S. J., Kim,, E. H., Lee,, S. H., Kim,, H. K., … Kim,, G. S. (2012). Iron overload accelerates bone loss in healthy postmenopausal women and middle‐aged men: A 3‐year retrospective longitudinal study. Journal of Bone and Mineral Research, 27(11), 2279–2290. https://doi.org/10.1002/jbmr.1692
Kim,, K. S., Son,, H. G., Hong,, N. S., & Lee,, D. H. (2012). Associations of serum ferritin and transferrin % saturation with all‐cause, cancer, and cardiovascular disease mortality: Third National Health and Nutrition Examination Survey follow‐up study. Journal of Preventive Medicine and Public Health, 45(3), 196–203. https://doi.org/10.3961/jpmph.2012.45.3.196
Kim,, S. E., Zhang,, L., Ma,, K., Riegman,, M., Chen,, F., Ingold,, I., … Jiang,, X. (2016). Ultrasmall nanoparticles induce ferroptosis in nutrient‐deprived cancer cells and suppress tumour growth. Nature Nanotechnology, 11(11), 977–985. https://doi.org/10.1038/nnano.2016.164
Kraml,, P. (2017). The role of iron in the pathogenesis of atherosclerosis. Physiological Research, 66, S55–S67. https://doi.org/10.33549/physiolres.933589
Krishnamurthy,, P., Xie,, T., & Schuetz,, J. D. (2007). The role of transporters in cellular heme and porphyrin homeostasis. Pharmacology %26 Therapeutics, 114(3), 345–358. https://doi.org/10.1016/j.pharmthera.2007.02.001
Lee,, S., Song,, A., & Eo,, W. (2016). Serum ferritin as a prognostic biomarker for survival in relapsed or refractory metastatic colorectal cancer. Journal of Cancer, 7(8), 957–964. https://doi.org/10.7150/jca.14797
Liang,, C., Zhang,, X. L., Yang,, M. S., & Dong,, X. C. (2019). Recent progress in ferroptosis inducers for cancer therapy. Advanced Materials, 31(51), e1904197. https://doi.org/10.1002/adma.201904197
Liu,, L., Zhong,, T., Xu,, Q., & Chen,, Y. (2015). Efficient molecular imprinting strategy for quantitative targeted proteomics of human transferrin receptor in depleted human serum. Analytical Chemistry, 87(21), 10910–10919. https://doi.org/10.1021/acs.analchem.5b02633
Liu,, T., Liu,, W., Zhang,, M., Yu,, W., Gao,, F., Li,, C., … Zhang,, X.‐Z. (2018). Ferrous‐supply‐regeneration nanoengineering for cancer‐cell‐specific ferroptosis in combination with imaging‐guided photodynamic therapy. ACS Nano, 12(12), 12181–12192. https://doi.org/10.1021/acsnano.8b05860
Liu,, Y., Zhang,, N., Li,, P., Yu,, L., Chen,, S., Zhang,, Y., … Peng,, W. (2019). Low‐cost localized surface plasmon resonance biosensing platform with a response enhancement for protein detection. Nanomaterials (Basel), 9(7), 1019. https://doi.org/10.3390/nano9071019
Liuzzi,, J. P., Aydemir,, F., Nam,, H., Knutson,, M. D., & Cousins,, R. J. (2006). Zip14 (Slc39a14) mediates non‐transferrin‐bound iron uptake into cells. Proceedings of the National Academy of Sciences of the United States of America, 103(37), 13612–13617. https://doi.org/10.1073/pnas.0606424103
Lu,, M., Cohen,, M. H., Rieves,, D., & Pazdur,, R. (2010). FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease. American Journal of Hematology, 85(5), 315–319. https://doi.org/10.1002/ajh.21656
Ma,, P. a., Xiao,, H., Yu,, C., Liu,, J., Cheng,, Z., Song,, H., … Gu,, Z. (2017). Enhanced cisplatin chemotherapy by iron oxide nanocarrier‐mediated generation of highly toxic reactive oxygen species. Nano Letters, 17(2), 928–937. https://doi.org/10.1021/acs.nanolett.6b04269
Masaldan,, S., Bush,, A. I., Devos,, D., Rolland,, A. S., & Moreau,, C. (2019). Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration. Free Radical Biology and Medicine, 133, 221–233. https://doi.org/10.1016/j.freeradbiomed.2018.09.033
Mazzone,, M., Menga,, A., & Castegna,, A. (2018). Metabolism and TAM functions—It takes two to tango. The FEBS Journal, 285(4), 700–716. https://doi.org/10.1111/febs.14295
McKie,, A. T., Barrow,, D., Latunde‐Dada,, G. O., Rolfs,, A., Sager,, G., Mudaly,, E., … Simpson,, R. J. (2001). An iron‐regulated ferric reductase associated with the absorption of dietary iron. Science, 291(5509), 1755–1759. https://doi.org/10.1126/science.1057206
Mertens,, C., Mora,, J., Ören,, B., Grein,, S., Winslow,, S., Scholich,, K., … Fernö,, M. (2018). Macrophage‐derived lipocalin‐2 transports iron in the tumor microenvironment. Oncoimmunology, 7(3), e1408751. https://doi.org/10.1080/2162402X.2017.1408751
Mu,, X. Y., Qi,, L., Dong,, P., Qiao,, J., Hou,, J., Nie,, Z. X., & Ma,, H. M. (2013). Facile one‐pot synthesis of L‐proline‐stabilized fluorescent gold nanoclusters and its application as sensing probes for serum iron. Biosensors %26 Bioelectronics, 49, 249–255. https://doi.org/10.1016/j.bios.2013.05.019
Muckenthaler,, M. U., Rivella,, S., Hentze,, M. W., & Galy,, B. (2017). A red carpet for iron metabolism. Cell, 168(3), 344–361. https://doi.org/10.1016/j.cell.2016.12.034
Müller,, K., Skepper,, J. N., Posfai,, M., Trivedi,, R., Howarth,, S., Corot,, C., … Gillard,, J. H. (2007). Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran‐10) on human monocyte‐macrophages in vitro. Biomaterials, 28(9), 1629–1642. https://doi.org/10.1016/j.biomaterials.2006.12.003
Nairz,, M., Haschka,, D., Demetz,, E., & Weiss,, G. (2014). Iron at the interface of immunity and infection. Frontiers in Pharmacology, 5, 152. https://doi.org/10.3389/fphar.2014.00152
Nemeth,, E., Tuttle,, M. S., Powelson,, J., Vaughn,, M. B., Donovan,, A., Ward,, D. M., … Kaplan,, J. (2004). Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science, 306(5704), 2090–2093. https://doi.org/10.1126/science.1104742
Ohgami,, R. S., Campagna,, D. R., Greer,, E. L., Antiochos,, B., McDonald,, A., Chen,, J., … Fleming,, M. D. (2005). Identification of a ferrireductase required for efficient transferrin‐dependent iron uptake in erythroid cells. Nature Genetics, 37(11), 1264–1269. https://doi.org/10.1038/ng1658
Ohgami,, R. S., Campagna,, D. R., McDonald,, A., & Fleming,, M. D. (2006). The Steap proteins are metalloreductases. Blood, 108(4), 1388–1394. https://doi.org/10.1182/blood-2006-02-003681
Ou,, W., Mulik,, R. S., Anwar,, A., McDonald,, J. G., He,, X., & Corbin,, I. R. (2017). Low‐density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma. Free Radical Biology and Medicine, 112, 597–607. https://doi.org/10.1016/j.freeradbiomed.2017.09.002
Pagani,, A., Nai,, A., Corna,, G., Bosurgi,, L., Rovere‐Querini,, P., Camaschella,, C., & Silvestri,, L. (2011). Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood, 118(3), 736–746. https://doi.org/10.1182/blood-2011-02-337212
Park,, S., Kosmider,, O., Maloisel,, F., Drenou,, B., Chapuis,, N., Lefebvre,, T., … Fontenay,, M. (2019). Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower‐risk myelodysplastic syndromes. Haematologica, 104(3), 497–504. https://doi.org/10.3324/haematol.2018.203158
Pereira,, D. I., Mohammed,, N. I., Ofordile,, O., Camara,, F., Baldeh,, B., Mendy,, T., … Wason,, J. (2018). A novel nano‐iron supplement to safely combat iron deficiency and anaemia in young children: The IHAT‐GUT double‐blind, randomised, placebo‐controlled trial protocol. Gates Open Research, 2, 48–48. https://doi.org/10.12688/gatesopenres.12866.2
Pereira,, D. I. A., Bruggraber,, S. F. A., Faria,, N., Poots,, L. K., Tagmount,, M. A., Aslam,, M. F., … Powell,, J. J. (2014). Nanoparticulate iron(III) oxo‐hydroxide delivers safe iron that is well absorbed and utilised in humans. Nanomedicine‐Nanotechnology Biology and Medicine, 10(8), 1877–1886. https://doi.org/10.1016/j.nano.2014.06.012
Peterson,, R. D., Chen,, W. L., Cunningham,, B. T., & Andrade,, J. E. (2015). Enhanced sandwich immunoassay using antibody‐functionalized magnetic iron‐oxide nanoparticles for extraction and detection of soluble transferrin receptor on a photonic crystal biosensor. Biosensors %26 Bioelectronics, 74, 815–822. https://doi.org/10.1016/j.bios.2015.07.050
Peterson,, R. D., Cunningham,, B. T., & Andrade,, J. E. (2014). A photonic crystal biosensor assay for ferritin utilizing iron‐oxide nanoparticles. Biosensors %26 Bioelectronics, 56, 320–327. https://doi.org/10.1016/j.bios.2014.01.022
Pinnix,, Z. K., Miller,, L. D., Wang,, W., D`Agostino,, R., Kute,, T., Willingham,, M. C., … Di,, X. (2010). Ferroportin and iron regulation in breast cancer progression and prognosis. Science Translational Medicine, 2(43), 43ra56. https://doi.org/10.1126/scisignal.3001127
Priyadarshini,, E., Rawat,, K., Bohidar,, H. B., & Rajamani,, P. (2019). Dual‐probe (colorimetric and fluorometric) detection of ferritin using antibody‐modified gold@carbon dot nanoconjugates. Microchimica Acta, 186(11), 687. https://doi.org/10.1007/s00604-019-3802-1
Puntarulo,, S. (2005). Iron, oxidative stress and human health. Molecular Aspects of Medicine, 26(4–5), 299–312. https://doi.org/10.1016/j.mam.2005.07.001
Recalcati,, S., Locati,, M., Gammella,, E., Invernizzi,, P., & Cairo,, G. (2012). Iron levels in polarized macrophages: Regulation of immunity and autoimmunity. Autoimmunity Reviews, 11(12), 883–889. https://doi.org/10.1016/j.autrev.2012.03.003
Reichel,, D., Tripathi,, M., & Perez,, J. M. (2019). Biological effects of nanoparticles on macrophage polarization in the tumor microenvironment. Nanotheranostics, 3(1), 66–88. https://doi.org/10.7150/ntno.30052
Rojas,, J. M., Sanz‐Ortega,, L., Mulens‐Arias,, V., Gutiérrez,, L., Pérez‐Yagüe,, S., & Barber,, D. F. (2016). Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion. Nanomedicine: Nanotechnology, Biology and Medicine, 12(4), 1127–1138. https://doi.org/10.1016/j.nano.2015.11.020
R`zik,, S., Loo,, M., & Beguin,, Y. (2001). Reticulocyte transferrin receptor (TfR) expression and contribution to soluble TfR levels. Haematologica, 86(3), 244–251. https://doi.org/10.1016/S0301-472X(00)00674-3
Salvati,, A., Pitek,, A. S., Monopoli,, M. P., Prapainop,, K., Bombelli,, F. B., Hristov,, D. R., … Dawson,, K. A. (2013). Transferrin‐functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nature Nanotechnology, 8(2), 137–143. https://doi.org/10.1038/NNANO.2012.237
Schreiber,, R. D., Old,, L. J., & Smyth,, M. J. (2011). Cancer immunoediting: Integrating immunity`s roles in cancer suppression and promotion. Science, 331(6024), 1565–1570. https://doi.org/10.1126/science.1203486
Shaw,, G. C., Cope,, J. J., Li,, L. T., Corson,, K., Hersey,, C., Ackermann,, G. E., … Paw,, B. H. (2006). Mitoferrin is essential for erythroid iron assimilation. Nature, 440(7080), 96–100. https://doi.org/10.1038/nature04512
Shen,, Z., Liu,, T., Li,, Y., Lau,, J., Yang,, Z., Fan,, W., … Bregadze,, V. I. (2018). Fenton‐reaction‐acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors. ACS Nano, 12(11), 11355–11365. https://doi.org/10.1021/acsnano.8b06201
Sindrilaru,, A., Peters,, T., Wieschalka,, S., Baican,, C., Baican,, A., Peter,, H., … Scharffetter‐Kochanek,, K. (2011). An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. Journal of Clinical Investigation, 121(3), 985–997. https://doi.org/10.1172/Jci44490
Singh,, Y. P., Pandey,, A., Vishwakarma,, S., & Modi,, G. (2019). A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer`s and Parkinson`s diseases. Molecular Diversity, 23(2), 509–526. https://doi.org/10.1007/s11030-018-9878-4
Sposi,, N. M., Cianetti,, L., Tritarelli,, E., Pelosi,, E., Militi,, S., Barberi,, T., … Testa,, U. (2000). Mechanisms of differential transferrin receptor expression in normal hematopoiesis. European Journal of Biochemistry, 267(23), 6762–6774. https://doi.org/10.1046/j.1432-1033.2000.01769.x
Srinivasan,, B., Finkelstein,, J. L., O`Dell,, D., Erickson,, D., & Mehta,, S. (2019). Rapid diagnostics for point‐of‐care quantification of soluble transferrin receptor. eBioMedicine, 42, 504–510. https://doi.org/10.1016/j.ebiom.2019.03.017
Srinivasan,, B., O`Dell,, D., Finkelstein,, J. L., Lee,, S., Erickson,, D., & Mehta,, S. (2018). ironPhone: Mobile device‐coupled point‐of‐care diagnostics for assessment of iron status by quantification of serum ferritin. Biosensors %26 Bioelectronics, 99, 115–121. https://doi.org/10.1016/j.bios.2017.07.038
Stockwell,, B. R., Angeli,, J. P. F., Bayir,, H., Bush,, A. I., Conrad,, M., Dixon,, S. J., … Zhang,, D. D. (2017). Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell, 171(2), 273–285. https://doi.org/10.1016/j.cell.2017.09.021
Sun,, X., Ou,, Z., Xie,, M., Kang,, R., Fan,, Y., Niu,, X., … Tang,, D. (2015). HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene, 34(45), 5617–5625. https://doi.org/10.1038/onc.2015.32
Tarangelo,, A., & Dixon,, S. J. (2016). Nanomedicine: An iron age for cancer therapy. Nature Nanotechnology, 11(11), 921–922. https://doi.org/10.1038/nnano.2016.199
Theurl,, I., Aigner,, E., Theurl,, M., Nairz,, M., Seifert,, M., Schroll,, A., … Weiss,, G. (2009). Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: Diagnostic and therapeutic implications. Blood, 113(21), 5277–5286. https://doi.org/10.1182/blood-2008-12-195651
Torti,, S. V., & Torti,, F. M. (2013). Iron and cancer: More ore to be mined. Nature Reviews Cancer, 13(5), 342–355. https://doi.org/10.1038/nrc3495
Toyokuni,, S., Ito,, F., Yamashita,, K., Okazaki,, Y., & Akatsuka,, S. (2017). Iron and thiol redox signaling in cancer: An exquisite balance to escape ferroptosis. Free Radical Biology and Medicine, 108, 610–626. https://doi.org/10.1016/j.freeradbiomed.2017.04.024
Treffry,, A., & Harrison,, P. M. (1979). The binding of ferric iron by ferritin. Biochemical Journal, 181(3), 709–716. https://doi.org/10.1042/bj1810709
Tripathi,, A. K., Haldar,, S., Qian,, J., Beserra,, A., Suda,, S., Singh,, A., … Singh,, N. (2015). Prion protein functions as a ferrireductase partner for ZIP14 and DMT1. Free Radical Biology and Medicine, 84, 322–330. https://doi.org/10.1016/j.freeradbiomed.2015.03.037
Trujillo‐Alonso,, V., Pratt,, E. C., Zong,, H. L., Lara‐Martinez,, A., Kaittanis,, C., Rabie,, M. O., … Guzman,, M. L. (2019). FDA‐approved ferumoxytol displays anti‐leukaemia efficacy against cells with low ferroportin levels. Nature Nanotechnology, 14(6), 616–622. https://doi.org/10.1038/s41565-019-0406-1
Truman‐Rosentsvit,, M., Berenbaum,, D., Spektor,, L., Cohen,, L. A., Belizowsky‐Moshe,, S., Lifshitz,, L., … Meyron‐Holtz,, E. G. (2018). Ferritin is secreted via 2 distinct nonclassical vesicular pathways. Blood, 131(3), 342–352. https://doi.org/10.1182/blood-2017-02-768580
Vinchi,, F., Porto,, G., Simmelbauer,, A., Altamura,, S., Passos,, S. T., Garbowski,, M., … Sparla,, R. (2019). Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction. European Heart Journal, 41, 2681–2695. https://doi.org/10.1093/eurheartj/ehz112
Vinchi,, F., Sparla,, R., Simmelbauer,, A., Altamura,, S., Speich,, S., Galy,, B., … Muckenthaler,, M. U. (2017). Low‐iron diet and chelation therapy rescue severe atherosclerosis associated with high circulating iron levels. Atherosclerosis, 263, E15–E16. https://doi.org/10.1016/j.atherosclerosis.2017.06.076
Walden,, W. E., Selezneva,, A. I., Dupuy,, J., Volbeda,, A., Fontecilla‐Camps,, J. C., Theil,, E. C., & Volz,, K. (2006). Structure of dual function iron regulatory protein 1 complexed with ferritin IRE‐RNA. Science, 314(5807), 1903–1908. https://doi.org/10.1126/science.1133116
Wang,, C., Graham,, D. J., Kane,, R. C., Xie,, D., Wernecke,, M., Levenson,, M., … Wong,, S. (2015). Comparative risk of anaphylactic reactions associated with intravenous iron products. JAMA, 314(19), 2062–2068. https://doi.org/10.1001/jama.2015.15572
Wang,, C. Y., Jenkitkasemwong,, S., Duarte,, S., Sparkman,, B. K., Shawki,, A., Mackenzie,, B., & Knutson,, M. D. (2012). ZIP8 is an iron and zinc transporter whose cell‐surface expression is up‐regulated by cellular iron loading. Journal of Biological Chemistry, 287(41), 34032–34043. https://doi.org/10.1074/jbc.M112.367284
Wang,, K., Zhang,, Y., Wang,, J., Yuan,, A., Sun,, M., Wu,, J., & Hu,, Y. (2016). Self‐assembled IR780‐loaded transferrin nanoparticles as an imaging, targeting and PDT/PTT agent for cancer therapy. Scientific Reports, 6, 27421. https://doi.org/10.1038/srep27421
Wang,, N., Jin,, X., Guo,, D., Tong,, G., & Zhu,, X. (2016). Iron chelation nanoparticles with delayed saturation as an effective therapy for Parkinson disease. Biomacromolecules, 18(2), 461–474. https://doi.org/10.1021/acs.biomac.6b01547
Wang,, Y., Chen,, J.‐T., & Yan,, X.‐P. (2013). Fabrication of transferrin functionalized gold nanoclusters/graphene oxide nanocomposite for turn‐on near‐infrared fluorescent bioimaging of cancer cells and small animals. Analytical Chemistry, 85(4), 2529–2535. https://doi.org/10.1021/ac303747t
Wang,, Z., Huang,, P., Jacobson,, O., Wang,, Z., Liu,, Y., Lin,, L., … Tian,, R. (2016). Biomineralization‐inspired synthesis of copper sulfide–ferritin nanocages as cancer theranostics. ACS Nano, 10(3), 3453–3460. https://doi.org/10.1021/acsnano.5b07521
Weerathunge,, P., Pooja,, D., Singh,, M., Kulhari,, H., Mayes,, E. L., Bansal,, V., & Ramanathan,, R. (2019). Transferrin‐conjugated quasi‐cubic SPIONs for cellular receptor profiling and detection of brain cancer. Sensors and Actuators B: Chemical, 297, 126737. https://doi.org/10.1016/j.snb.2019.126737
Weinberg,, E. D. (2009). Iron availability and infection. Biochimica et Biophysica Acta‐General Subjects, 1790(7), 600–605. https://doi.org/10.1016/j.bbagen.2008.07.002
Wilkinson,, N., & Pantopoulos,, K. (2014). The IRP/IRE system in vivo: Insights from mouse models. Frontiers in Pharmacology, 5, 176. https://doi.org/10.3389/fphar.2014.00176
Wish,, J. B. (2006). Assessing iron status: Beyond serum ferritin and transferrin saturation. Clinical Journal of the American Society of Nephrology, 1, S4–S8. https://doi.org/10.2215/CJN.01490506
Wu,, J., Minikes,, A. M., Gao,, M. H., Bian,, H. J., Li,, Y., Stockwell,, B. R., … Jiang,, X. J. (2019). Intercellular interaction dictates cancer cell ferroptosis via NF2‐YAP signalling. Nature, 572(7769), 402–406. https://doi.org/10.1038/s41586-019-1426-6
Yang,, J., Bielenberg,, D. R., Rodig,, S. J., Doiron,, R., Clifton,, M. C., Kung,, A. L., … Moses,, M. A. (2009). Lipocalin 2 promotes breast cancer progression. Proceedings of the National Academy of Sciences, 106(10), 3913–3918. https://doi.org/10.1073/pnas.0810617106
Yang,, R., Li,, Y., Wang,, X., Yan,, J., Pan,, D., Xu,, Y., … Yang,, M. (2019). Doxorubicin loaded ferritin nanoparticles for ferroptosis enhanced targeted killing of cancer cells. RSC Advances, 9(49), 28548–28553. https://doi.org/10.1039/C9RA04478G
Yang,, W. S., SriRamaratnam,, R., Welsch,, M. E., Shimada,, K., Skouta,, R., Viswanathan,, V. S., … Clish,, C. B. (2014). Regulation of ferroptotic cancer cell death by GPX4. Cell, 156(1–2), 317–331. https://doi.org/10.1016/j.cell.2013.12.010
Yen,, L.‐C., Pan,, T.‐M., Lee,, C.‐H., & Chao,, T.‐S. (2016). Label‐free and real‐time detection of ferritin using a horn‐like polycrystalline‐silicon nanowire field‐effect transistor biosensor. Sensors and Actuators B: Chemical, 230, 398–404. https://doi.org/10.1016/j.snb.2016.02.095
You,, L., Wang,, J., Liu,, T., Zhang,, Y., Han,, X., Wang,, T., … Anderson,, G. J. (2018). Targeted brain delivery of rabies virus glycoprotein 29‐modified deferoxamine‐loaded nanoparticles reverses functional deficits in parkinsonian mice. ACS Nano, 12(5), 4123–4139. https://doi.org/10.1021/acsnano.7b08172
Zanganeh,, S., Hutter,, G., Spitler,, R., Lenkov,, O., Mahmoudi,, M., Shaw,, A., … Moseley,, M. (2016). Iron oxide nanoparticles inhibit tumour growth by inducing pro‐inflammatory macrophage polarization in tumour tissues. Nature Nanotechnology, 11(11), 986–994. https://doi.org/10.1038/nnano.2016.168
Zecca,, L., Youdim,, M. B. H., Riederer,, P., Connor,, J. R., & Crichton,, R. R. (2004). Iron, brain ageing and neurodegenerative disorders. Nature Reviews Neuroscience, 5(11), 863–873. https://doi.org/10.1038/nrn1537
Zhang,, W., Wang,, R., Li,, P., Zhang,, W., Pang,, X., Wang,, H., & Tang,, B. (2019). Fluorescence biosensor for Fe (III) in cells based on Fe (III) catalyze Au‐nanocomposites release Au NPs. Sensors and Actuators B: Chemical, 286, 16–21. https://doi.org/10.1016/j.snb.2019.01.106
Zhang,, Y. D., Huang,, Q. W., Ma,, C., Liu,, X. Y., & Zhang,, H. X. (2018). Magnetic fluorescent molecularly imprinted nanoparticles for detection and separation of transferrin in human serum. Talanta, 188, 540–545. https://doi.org/10.1016/j.talanta.2018.06.002
Zhou,, Z., Song,, J., Tian,, R., Yang,, Z., Yu,, G., Lin,, L., … Niu,, G. (2017). Activatable singlet oxygen generation from lipid hydroperoxide nanoparticles for cancer therapy. Angewandte Chemie International Edition, 56(23), 6492–6496. https://doi.org/10.1002/ange.201701181
Ziem,, F. C., Götz,, N. S., Zappe,, A., Steinert,, S., & Wrachtrup,, J. r. (2013). Highly sensitive detection of physiological spins in a microfluidic device. Nano Letters, 13(9), 4093–4098. https://doi.org/10.1021/nl401522a

Access to this WIREs title is by subscription only.

Recommend to Your
Librarian Now!

The latest WIREs articles in your inbox

Sign Up for Article Alerts